Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma

Leif Bjermer, Katharine Abbott-Banner, Kenneth Newman

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Efficacy and safety of a first-in-class inhaled PDE3/4 inhibitor (ensifentrine) vs salbutamol in asthma'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemical Compounds